Home » Topics » Medical technology

Medical technology
RSS

Public Financing of Biotechnology: April 2001

May 7, 2001

Astex Raises $32.5M To Grow X-ray Crystallography Platform

May 7, 2001

Pharmacyclics Regains Rights To Cancer Drug From Amersham

May 7, 2001

Other Financings Of Public Biotechnology Companies: April 2001

May 7, 2001

Biomira, Merck Sign $150M Cancer Vaccine Collaboration

May 4, 2001

Gene Therapy Restores Sight To Blind Dogs With Leber Congenital Amaurosis; Human Trials In View

May 4, 2001

Allow Specific Cell Cloning, BIO Urges Senate Hearing

May 4, 2001

Other News To Note

May 4, 2001

Correction

May 4, 2001

Gemin X Closes Second Round; Financing Pulls Down $12.6M

May 4, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...